Property and contrast-enhancement effects of lipid ultrasound contrast agent: a preliminary experimental study.
This work investigated the influence of some factors on the property in vitro of a self-made lipid ultrasound (US) contrast agent (LCA) and evaluated the relationship of acoustic pressure and enhancement effect in normal rabbit kidney parenchyma. In the in vitro studies, filling gas, solvent and concentration of LCA solution were investigated. Morphologic characteristics, concentration and mean diameter of microbubbles were considered as indices. In the in vivo studies, contrast-tuned imaging (CnTi) technique was used to investigate the enhancement effects in kidney parenchyma under nine acoustic pressure levels. Among the samples saturated with different filling gases, perfluoropropane (C(3)F(8)) resulted in the highest concentration of microbubbles and air, the lowest. Microbubbles filled with C(3)F(8) or sulfur hexafluoride (SF(6)) were quite stable and remained at a high level of concentration (above 2 x 10(9) microbubbles per mL) much longer than did air-filled microbubbles. Among the four solutions tested, 5% glucose solution and 0.9% saline solution showed higher initial concentrations and greater longevity than dextran 40 glucose solution (6%) or distilled water. The concentration of LCA solution had a positive correlation with the microbubble concentration. All microbubble samples under different test conditions remained shape-complete and no aggregation or fusion was observed. The mean diameter of microbubble samples was about 3.4 microm. Contrast intensity and longevity of CnTi enhancement in vivo showed an acoustic-pressure-dependent decrease. At 1 kPa, contrast intensity increased 224-fold (4.47/0.02) and the longevity of CnTi enhancement in the kidney parenchyma remained longer.
Zhao
Ying-Zheng
YZ
Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China.
Luo
Yu-Kun
YK
Zhang
Yan
Y
Mei
Xing-Guo
XG
Tang
Jie
J
D000388:Air; D000818:Animals; D003287:Contrast Media; D005466:Fluorocarbons; D005947:Glucose; D007668:Kidney / Q000000981:diagnostic imaging*; D008055:Lipids; D008297:Male; D045423:Microbubbles; D011817:Rabbits; D012965:Sodium Chloride; D013459:Sulfur Hexafluoride; D018084:Ultrasonography, Interventional / Q000295:instrumentation / Q000379:methods*
D003287:Contrast Media; D005466:Fluorocarbons; D008055:Lipids; D012965:Sodium Chloride; C042852:perflutren; D005947:Glucose; D013459:Sulfur Hexafluoride